The pharmaceutical industry is undergoing a major transformation as drug delivery technologies evolve to address the growing complexity of modern therapies. Rising chronic disease prevalence, increasing adoption of biologics, and the development of high-potency and complex treatments are creating demand for drug delivery systems that can improve precision, stability, convenience, and patient adherence.
According to the Pharmaceutical Drug Delivery Market report by MarketsandMarkets, the global market is projected to reach USD 2,922.82 billion by 2031, up from USD 2,152.45 billion in 2026, registering a CAGR of 6.3% during the forecast period.
View the Pharmaceutical Drug Delivery Market report
Rising Demand for Advanced Drug Delivery Technologies
The growing burden of cancer, diabetes, cardiovascular disorders, and other chronic conditions is increasing the need for effective and convenient treatment options. At the same time, the pharmaceutical pipeline is shifting toward biologics, biosimilars, vaccines, mRNA therapies, and cell and gene therapies, many of which require specialized delivery approaches.
Advanced technologies such as autoinjectors, wearable injectors, inhalers, lipid nanoparticles, controlled-release formulations, prefilled syringes, and transdermal systems are increasingly being adopted to improve drug administration.
These technologies can help maintain drug stability, support accurate dosing, reduce administration frequency, and improve patient convenience. The growing emphasis on self-administration is also encouraging pharmaceutical manufacturers to develop delivery systems that can be safely used outside traditional hospital settings.
Injectable Drug Delivery Emerges as a Major Growth Segment
By administration route, the market includes oral, injectable, topical, ocular, nasal, transmucosal and implantable, pulmonary, and transdermal patch drug delivery systems.
Among these, injectable drug delivery is projected to hold a major market share in 2031. The segment is benefiting from the increasing use of biologics, biosimilars, monoclonal antibodies, vaccines, and advanced therapies that frequently require parenteral administration.
Injectable systems provide several advantages, including accurate dosing, rapid therapeutic action, and high bioavailability. These characteristics are particularly important for complex and high-potency therapies used to manage cancer, diabetes, autoimmune diseases, and other chronic conditions.
The emergence of long-acting injectables, depot formulations, targeted delivery systems, prefilled syringes, autoinjectors, and wearable injectors is further changing the injectable drug delivery landscape.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1085
Self-Administration and Home-Based Care Transform Drug Delivery
One of the most important trends in the pharmaceutical drug delivery market is the movement toward patient-centric administration. Healthcare systems are increasingly shifting appropriate treatments from hospitals and clinics toward outpatient and home-care environments.
Drug delivery devices that simplify administration can support this transition by enabling patients to manage certain therapies independently. Autoinjectors and wearable injectors, for example, can reduce the complexity associated with administering injectable medications.
This shift can also improve convenience and potentially support medication adherence by reducing the need for frequent healthcare visits. As healthcare becomes increasingly decentralized, pharmaceutical companies are focusing on drug-device combinations designed around usability, safety, and patient experience.
Formulations Segment Expected to Register Strong Growth
By facility of use, the formulations segment is anticipated to register the highest CAGR from 2026 to 2031.
Increasing demand for pharmaceutical formulations is being supported by the rising prevalence of acute and chronic diseases and growing patient volumes. The expansion of outpatient services and home-based care is further increasing the need for formulations that can be administered conveniently across different healthcare settings.
While hospitals remain important for complex treatments, decentralized care is creating new opportunities for drug delivery technologies that support administration in ambulatory and home-care environments.
Advances in formulation science are also helping address challenges related to drug stability, bioavailability, controlled release, and delivery of complex molecules.
Advanced Therapies Create New Opportunities
The growing adoption of biologics and other advanced therapies is one of the most significant opportunities for the industry. Many biologic drugs are sensitive to environmental conditions and may require specialized delivery systems to preserve stability and therapeutic effectiveness.
The emergence of mRNA therapies, cell and gene therapies, and high-viscosity biologics is creating demand for innovative delivery technologies. Lipid nanoparticles and other advanced carrier systems are being explored to improve the delivery of complex therapeutic molecules.
Similarly, controlled-release and targeted delivery technologies can potentially reduce dosing frequency and improve therapeutic outcomes. These developments are expanding the role of drug delivery from simply administering a medication toward optimizing how and where a therapy acts within the body.
Asia Pacific to Register the Highest Growth Rate
Asia Pacific is expected to record the highest growth rate between 2026 and 2031. The region is benefiting from its large and growing patient population, increasing prevalence of chronic diseases, expanding healthcare infrastructure, and rising healthcare expenditure.
Countries such as China, India, and Japan are witnessing increasing demand for advanced therapeutics and innovative drug delivery technologies. Government initiatives aimed at strengthening healthcare infrastructure, expanding access to medicines, and supporting domestic pharmaceutical manufacturing are contributing to the region’s growth.
The increasing presence of global pharmaceutical companies and investments in research and development are also accelerating the adoption of advanced drug delivery solutions.
Asia Pacific is additionally becoming an important pharmaceutical manufacturing and outsourcing hub. Cost advantages, expanding manufacturing capabilities, and the growing presence of contract development and manufacturing organizations (CDMOs) are strengthening the region’s position in the global pharmaceutical ecosystem.
Challenges in Drug Delivery Development
Despite strong growth opportunities, developing advanced drug delivery systems remains technically and financially challenging. Drug-device combination products can require sophisticated manufacturing processes, specialized materials, extensive testing, and stringent quality controls.
Regulatory requirements are also becoming increasingly demanding. Agencies including the FDA, EMA, PMDA, NMPA, and CDSCO continue to emphasize safety, usability, product quality, and device performance.
These requirements can increase development timelines and costs, particularly for innovative drug delivery systems that combine pharmaceutical formulations with sophisticated delivery devices.
Competitive Landscape
The pharmaceutical drug delivery market features major pharmaceutical companies as well as specialized drug delivery device manufacturers.
Prominent players in pharmaceutical drug delivery formulations include Johnson & Johnson Services, Pfizer, F. Hoffmann-La Roche, Eli Lilly and Company, Novartis, GSK, AbbVie, Sanofi, Merck & Co., and Amgen.
Major players in drug delivery devices include BD, Cardinal Health, SHL Medical, Gerresheimer, and Stevanato Group.
These companies are focusing on product innovation, strategic collaborations, advanced formulations, device development, and technologies designed to improve patient convenience and therapeutic outcomes.
The Future of Pharmaceutical Drug Delivery
The future of the pharmaceutical drug delivery market will increasingly revolve around precision, personalization, convenience, and decentralized treatment. Injectable systems, wearable delivery devices, advanced formulations, controlled-release technologies, and novel delivery platforms are expected to play important roles.
The combination of rising chronic disease prevalence with the rapid development of biologics and advanced therapies is creating a strong need for delivery technologies capable of handling increasingly complex medicines.
With the global market projected to reach USD 2,922.82 billion by 2031, drug delivery is evolving from a supporting function into a critical component of pharmaceutical innovation. Companies that successfully combine advanced formulations, intuitive devices, digital technologies, and patient-centric design will be well positioned to shape the next generation of medication delivery.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1085
